Detection of specific lytic and latent transcripts can help to predict the status of Epstein-Barr virus infection in transplant recipients with high virus load

Acta Biochimica Polonica

Volumn 55, Issue 4, 2008, Pages 693-699

  Zawilinska, Barbara ^a   Kosinska, Anna ^b   Lenart, Marzena ^b   Kopec, Jolanta ^b   Piatkowska Jakubas, Beata ^a   Skotnicki, Aleksander ^a   Kosz Vnenchak, Magdalena ^a,b  

^a JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

^b JAGIELLONIAN UNIVERSITY   (Poland)

Author keywords

Bone marrow transplantation; EBV lymphoproliferative disorder; Epstein Barr virus; Latency; Productive infection

Indexed keywords

HERPESVIRIDAE; HUMAN HERPESVIRUS 4;

EID: 58149517837     PISSN: 0001527X     EISSN: 1734154X     Source Type: Journal    
DOI: 10.18388/abp.2008_3029     Document Type: Article

References (22)

1. Bai X, Rogers BB, Harkins PC, Sommerauer J, Squires R, Rotondo K, Quan A, Dawson DB, Scheuermann RH (2000) Predictive value of quantitative PCR-based viral burden analysis for eight human herpesviruses in pediatric solid organ transplant patients. J Mol Diagn 2: 191-201.
2. Barrett ChJ (2000) Post-transplantation lymphoproliferative disease. Herpes 7: 4-8.
3. Bergallo M, Costa C, Baro S, Musso T, Balbo L, Merlino Ch, Cavallo R (2007) Multiplex-nested RT-PCR to evaluate latent and lytic Epstein Barr virus gene expression. J Biotechnol 128: 462-476.
4. Bhatia S, Ramsay NK, Steinbuch M, Dusenbery KE, Shapiro RS, Weisdorf DJ, Robison LL, Miller JS, Neglia JP (1996) Malignant neoplasms following bone marrow transplantation. Blood 87: 3633-3639.
5. Guzik K, Bzowska M, Dobrucki J, Pryjma J (1999) Heat-shocked monocytes are resistant to Staphylococcus auterus-induced apoptotic DNA fragmentation due expression of HSP 72. Jnfect Immun 67: 4216-4222.
6. Hopwood PA, Brooks L, Parratt R, Hunt BJ, Bokhari M, Thomas JA, Yacoub M, Crawford DH (2002) Persistent Epstein-Barr virus infection: unrestricted latent and lytic viral gene expression in healthy immunosuppressed transplant recipients. Transplantation 74: 194-202.
7. Jebbink J, Bai X, Rogers BB, Dawson DB, Scheuermann RH, Domiati-Saad R (2003) Development of real-time PCR assays for the quantitative detection of Epstein-Barr virus and cytomegalovirus, comparison of TaqMan probes and molecular beacons. J Mol Diagn 5: 5-20.
8. Mundle S, Allampallam K, Aftab Rashid K, Dangerfield B, Cartlidge J, Zeitler D, Afenya E, Alvi S, Shetty V, Venugopal P, Raza A (2001) Presence of activation-related mRNA for EBV and CMV in the bone marrow of patients with myelodysplastic syndromes. Cancer Lett 164: 197-205.
9. Nalesnik MA (1998) Clinical and pathological features of posttransplant lymphoproliferative disorders (PTLD). Springer Semin Immunopathol 29: 325-342.
10. Prang N, Hornem M, Jäger M, Wagner HJ, Wolf H, Schwarzman FM (1997) Lytic replication of Epstein-Barr virus in the peripheral blood: analysis of viral gene expression in B lymphocytes during infectious mononucleosis and in the normal carrier state. Blood 89: 1665-1677.
11. Qu L, Green M, Webber S, Reyes J, Ellis D, Rowe D (2000) Epstein-Barr virus gene expression in the peripheral blood of transplant recipients with persistent circulating virus loads. J Infect Dis 182: 1013-1021.
12. Rayes N, Seehofer D, Lullius SG, Stein A, May G, Kahl A, Frei U, Neuhaus P, Meisel H (2005) Monitoring of human cytomegalovirus, HHV-6 and HHV-7 infection in kidney transplant recipients by molecular methods to predict HCMV disease after transplantation: a prospective study. Ann Transplant 10: 23-28.
13. Rezonable RR, Paya CV (2003) Herpesvirus infections in transplant recipients: current challenges in the clinical management of cytomegalovirus and Epstein-Barr virus infections. Herpes 10: 60-65.
14. Rickinson AB, Kieff E (2007) Epstein-Barr virus. In Virology. Fields BN, Knipe DM, Howley PM, eds, pp 2655-2700. Lippincott-Raven Publishers, Philadelphia.
15. Savoie A, Perpete C, Carpentier L, Joncas J, Alfieri C (1994) Direct correlation between the load of Epstein-Barr virus-infected lymphocytes in the peripheral blood of pediatric transplant patients and risk of lymphoproliferative disorder. Blood 9: 2715-2722.
16. The TH, van den Berg AP, Harmsen MC, van der Bij W, van Son WJ (1995) The cytomegalovirus antigenemia assay: a plea for standardization. Scan J Infect Dis (Suppl) 99: 25-29.
17. Tsurumi T, Fujita M, Kudoh A (2005) Latent and lytic Epstein-Barr virus replication strategies. Rev Med Virol 15: 3-15.
18. Tysarowski A, Fabisiewicz A, Paszkiewicz-Kozik E, Kulik J, Walewski J, Siedlecki JA (2007) Usefulness of real-time PCR in long-term follow-up of follicular lymphoma patients. Acta Biochim Polon 54: 135-142.
19. Venard V, Carret AS, Pascal N, Rihn B, Bordigoni P, Le Faou A (2000) A convinient semi-quantitative method for the diagnosis of Epstein-Barr virus reactivation. Arch Virol 145: 2211-2216.
20. Wagner HJ, Rooney C, Heslop H (2002) Diagnosis and treatment of posttransplantation lymphoproliferative disease after hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 8: 1-8.
21. Wagner HJ, Cheng YC, Huls MH, Gee AP, Kuehnle I, Krance RA, Brenner MK, Rooney CM, Heslop HE (2004) Prompt versus preemptive intervention for EBV limphoproliferative disease. Blood 103: 3979-3981.
22. Zawilinska B, Bulek K, Kopec J, Kosz-Vnenchak M (2006) In situ detection of DNA and mRNA of human cytomegalovirus to distinguish defferent forms of viral infection in leukocytes. Acta Biochim Polon 53: 457-461.